Phase Forward and the Dana Farber Cancer Institute won an award from CIO magazine. “Our IT organization is honored by this recognition of our work in moving to electronic data capture (EDC) for clinical trials,” said Jeffrey Kessler, chief information officer, Dana-Farber. “EDC has reduced the time to access data from as much as eight weeks to real-time, and decreased the time to resolve queries from weeks to hours. This translates to more meaningful study results.” Here’s the release.

DataTrak has received a warning from NASDAQ. The exchange reminded the Cleveland company it needs “a minimum of $2,500,000 in stockholders’ equity or market value of $35,000,000 of listed securities or $500,000 of net income from continuing operations for the most recently completed fiscal year or two of the three most recently completed fiscal years.” The company faces a delisting of its stock but says it will provide a new plan by September 3, its announcement says.

{embed=“includes/banner_ads” loc=“middle”}

Nicox, a Pfizer partner, killed a Phase III trial of PF-03187207 for glaucoma and ocular hypertension trial in Asia. “We are also pleased by the progress that has been made in the research program focused on diabetic retinopathy, where we hope a lead compound will be selected in the first half of next year,” Nicox chairman and chief executive Michele Garufi said.

Axway and the Domino Group have formed a logistic partnership for clinical trials. Domino’s “Control” subsidiary, for which we cannot locate a web address, will handle the work. “Today’s pharmaceutical companies need to improve manufacturing production line efficiencies to meet the global demand for prescription drugs,” said John Pitts, sales and marketing director, Control. “This alliance marks an important step forward for the pharmaceutical companies, contract manufacturers and contract packagers.” Here’s the release.

{embed=“includes/banner_ads” loc=“third”}

The New York Times says touch-screen providers are optimistic that the Apple iPhone has helped consumers understand the value of their technology. Of particular excitement is the “multitouch” approach, which allows more than one fingertip to work in concert.

Nextrials, a northern California provider of electronic data capture, announced a higher ranking in the Inc. magazine list of the 5,000 fastest-growing private companies. “Nextrials continues to make market inroads as one of the leading developers of software and services for the pharmaceutical, biotechnology and medical device industries,” noted James Rogers, co-founder and CEO of Nextrials. “The improvement in our Inc. 5000 ranking this year is a direct result of the tremendous effort our employees have expended to deliver superior customer service and software tools that address real client needs, setting us apart from our competition and helping us achieve record sales.” The company’s finances are private, but it is reporting a 155 percent increase in sales over three years. Here’s the release.

Have a news release? Send it to .